Breaking News Instant updates and real-time market news.

IGT

International Game

$27.63

-0.27 (-0.97%)

07:35
11/29/17
11/29
07:35
11/29/17
07:35

International Game upgraded to Buy from Hold at Argus

IGT International Game
$27.63

-0.27 (-0.97%)

03/24/17
ARGS
03/24/17
DOWNGRADE
ARGS
Hold
International Game downgraded to Hold from Buy at Argus
Argus analyst John Staszak downgraded International Game to Hold due to management's recently projected projected 2017 EBITDA of flat to down 2%, to $1.68-$1.76B, below the prereporting consensus of $1.78B. The analyst said the company faces difficult Q1 comps and expects few casinos to open in the US in 2017, leading to flat spending on gaming equipment.
09/20/17
BOFA
09/20/17
UPGRADE
Target $30
BOFA
Buy
International Game upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Barry Jonas upgraded International Game to Buy and raised its price target to $30 from $24. The analyst sees upside to second half and 2018 estimates due to a stable and recurring business combined with conservative Street expectations. Further, the analyst expects Mega Million to be a tailwind to 2018 earnings as the lottery minimum moves to $2 from $1 and a change in the rules is implemented towards higher jackpots, more inline with Powerball.
09/26/17
DBAB
09/26/17
INITIATION
Target $30
DBAB
Buy
International Game resumed with a Buy from Hold at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli resumed coverage of International Game Technology and upgraded the shares to Buy with a $30 price target. The analyst sees a "meaningful upside opportunity" saying the company's fundamentals continue to improve in the high operating leverage and higher profile gaming segment.
11/20/17
DBAB
11/20/17
NO CHANGE
Target $34
DBAB
Buy
International Game price target raised to $34 from $30 at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli raised his price target for International Game Technology to $34 after hosting management for investor meetings. The analyst sees the recent run in shares as the "beginning of an extended period of upward momentum." The company's fundamentals continue to improve while investors have a greater appreciation for the stability of the lottery business, Santarelli tells investors in a research note. He affirms a Buy rating on International Game.

TODAY'S FREE FLY STORIES

IBB

iShares Nasdaq Biotechnology Index

$106.07

2.02 (1.94%)

09:50
12/11/17
12/11
09:50
12/11/17
09:50
Technical Analysis
Technical View: iShares Nasdaq Biotechnology Index breaks out »

The iShares Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$5.46

0.13 (2.44%)

09:50
12/11/17
12/11
09:50
12/11/17
09:50
Options
Interest in AK Steel Mar 7 calls continues »

Interest in AK Steel Mar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCE

Spark Therapeutics

$73.38

2.82 (4.00%)

09:48
12/11/17
12/11
09:48
12/11/17
09:48
Conference/Events
Spark Therapeutics to hold a pharmaceutical update conference call »

Management reviews the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 12

    Jan

NKE

Nike

$61.67

0.365 (0.60%)

09:47
12/11/17
12/11
09:47
12/11/17
09:47
Upgrade
Nike rating change  »

Nike upgraded to Positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

09:45
12/11/17
12/11
09:45
12/11/17
09:45
General news
JOLTS Job Openings to be reported at 10:00 »

October JOLTS Job…

IOTS

Adesto Technologies

$7.00

-0.45 (-6.04%)

09:44
12/11/17
12/11
09:44
12/11/17
09:44
Conference/Events
Adesto Technologies management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 14

    Dec

AGIO

Agios Pharmaceuticals

$60.97

0.14 (0.23%)

09:42
12/11/17
12/11
09:42
12/11/17
09:42
Conference/Events
Agios Pharmaceuticals to hold an investor meeting »

Investor Meeting where…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

KMB

Kimberly-Clark

09:41
12/11/17
12/11
09:41
12/11/17
09:41
Technical Analysis
Technical View: Kimberly-Clark falls in early trading, analyst action »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

, CELG

Celgene

$106.09

3.36 (3.27%)

09:40
12/11/17
12/11
09:40
12/11/17
09:40
Options
Unusually active option classes on open December 11th »

Unusual total active…

AKS

AK Steel

CELG

Celgene

$106.09

3.36 (3.27%)

GME

GameStop

CTL

CenturyLink

X

U.S. Steel

ORCL

Oracle

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Jan

  • 25

    Mar

09:40
12/11/17
12/11
09:40
12/11/17
09:40
General news
Fed funds futures are flat to lower ahead of Wednesday's FOMC »

Fed funds futures are…

ECR

Eclipse Resources

09:35
12/11/17
12/11
09:35
12/11/17
09:35
Conference/Events
Eclipse Resources to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTE

Baytex Energy

09:35
12/11/17
12/11
09:35
12/11/17
09:35
Downgrade
Baytex Energy rating change  »

Baytex Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNN

Smith & Nephew

09:33
12/11/17
12/11
09:33
12/11/17
09:33
Downgrade
Smith & Nephew rating change  »

Smith & Nephew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YPF

YPF

09:32
12/11/17
12/11
09:32
12/11/17
09:32
Upgrade
YPF rating change  »

YPF upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMS

Fresenius Medical

09:32
12/11/17
12/11
09:32
12/11/17
09:32
Downgrade
Fresenius Medical rating change  »

Fresenius Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEF

Telefonica

09:31
12/11/17
12/11
09:31
12/11/17
09:31
Downgrade
Telefonica rating change  »

Telefonica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEX

IDEX Corp.

09:31
12/11/17
12/11
09:31
12/11/17
09:31
Hot Stocks
IDEX Corp. announces acquisition of thinXXS Microtechnology AG »

IDEX Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

09:31
12/11/17
12/11
09:31
12/11/17
09:31
Downgrade
Home Depot rating change  »

Home Depot downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AIBSF

Allied Irish Banks

09:29
12/11/17
12/11
09:29
12/11/17
09:29
Downgrade
Allied Irish Banks rating change  »

Allied Irish Banks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$30.45

0.05 (0.16%)

09:29
12/11/17
12/11
09:29
12/11/17
09:29
Conference/Events
Argenx to hold a workshop »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

VTGN

VistaGen Therapeutics

$1.80

-0.23 (-11.33%)

09:27
12/11/17
12/11
09:27
12/11/17
09:27
Syndicate
VistaGen Therapeutics announces pricing of common stock and warrant offering »

VistaGen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

, CBOE

CBOE Holdings

$125.27

1.08 (0.87%)

09:26
12/11/17
12/11
09:26
12/11/17
09:26
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Fitbit (FIT), up…

FIT

Fitbit

CBOE

CBOE Holdings

$125.27

1.08 (0.87%)

NXPI

NXP Semiconductors

$115.29

0.16 (0.14%)

QURE

uniQure

$17.82

0.8 (4.70%)

CSIQ

Canadian Solar

$17.25

0.13 (0.76%)

PZRX

PhaseRx

$1.00

0.0126 (1.28%)

WPC

W.P. Carey

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NDAQ

Nasdaq

$78.78

0.99 (1.27%)

09:26
12/11/17
12/11
09:26
12/11/17
09:26
Recommendations
Nasdaq analyst commentary  »

Nasdaq price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RPT

Ramco-Gershenson

09:25
12/11/17
12/11
09:25
12/11/17
09:25
Conference/Events
Ramco-Gershenson to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

LITE

Lumentum

$49.60

1.05 (2.16%)

09:23
12/11/17
12/11
09:23
12/11/17
09:23
Upgrade
Lumentum rating change  »

Lumentum upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.